University of Texas at Dallas researchers applied their novel method to organic radical contrast agents with encouraging conclusions.

The National Kidney Foundation joined the college in releasing a new consensus document that answers key questions and offers recommendations for using IV contrast in patients with impaired kidney function.

The new approach offers more comprehensive information with no loss of image quality, and may alter the care landscape for patients with coronary artery disease.

The researchers analyzed 39 consecutive patients with 44 pathologically confirmed cirrhotic nodules who first received a CEUS exam, followed by a traditional follow-up ultrasound every three or four months for their study.

The American College of Radiology released the contrast-specific LI-RADS system in response to the widespread use of the material in clinical practice. To date, however, few studies have analyzed its interreader agreement, and in those that have, results have been inconsistent.

Using contrast-enhanced digital mammography (CEDM) to evaluate low to moderately suspicious breast lesions can greatly reduce biopsies in patients with benign lesions, according to a study published Sept. 5 in Academic Radiology.

Patients with a family or personal history of allergic reactions to contrast media are in danger of experiencing future reactions, according to a study published Sept. 3 in Radiology.  

The new agent is manganese-based (Mn-PyC3A) and produces tumor contrast enhancement similarly to that seen when using “state of the art” gadolinium-based contrast agents (GBCAs).